Skip to main content

Table 5 Treatment groups by duration and agents

From: Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts

Treatment Groups

n

%

Treated < 1 month or never

54

28.9

Treatment ≥1 month

133

71.1

Treatment > 3 months

123

65.8

Off treatment ≥12 months

22

11.8

Prednisone

131

70.1

Methylprednisolone

13

7.0

Methotrexate

59

31.6

Azathioprine

9

4.8

Mycophenolic acid

13

7.0

Hydroxychloroquine

16

8.6

Infliximab

14

7.5